Recently published in The New England Journal of Medicine1 results of a phase 3, double-blind, randomized trial show that the…
Metastatic Breast Cancer
Recently published in The New England Journal of Medicine, results from the phase 3, multicenter DESTINY-06 clinical trial show that…
Approximately 70% of advanced breast cancers are hormone receptor-positive (HR+)/HER2-negative. Hormone therapies are widely used for the treatment of patients…
